Bayer AktieWKN: BAY001 / ISIN: DE000BAY0017

107,78EUR
+2,06EUR
+1,95%
10:50:40
KAUFEN
VERKAUFEN

Bayer News

11.01.18
Bayer sells 10.4 percent stake in Covestro (EN, Bayer)
10.01.18
Bayer further reduces holding in Covestro (EN, Bayer)
20.12.17
Bayer announces initiation of rolling submission of new drug application in the U.S. for larotrectinib for the treatment of TRK fusion cancers (for specialized target groups only) (EN, Bayer)
13.12.17
Bayer receives approval in China for Stivarga® (regorafenib) for the second-line systemic treatment of liver cancer (for specialized target groups only) (EN, Bayer)
15.11.17
Heiko Schipper to join Bayer Board of Management and head Consumer Health Division (EN, Bayer)
15.11.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
14.11.17
Bayer and Loxo Oncology to develop and commercialize two novel oncology therapies selectively targeting genetic drivers of cancer (for specialized target groups only) (EN, Bayer)
06.11.17
Bayer submits application for marketing approval of rivaroxaban for patients with coronary or peripheral artery disease to European Medicines Agency (for specialized target groups only) (EN, Bayer)
02.11.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
02.11.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
02.11.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
30.10.17
Bayer receives FDA approval for Xarelto® 10 mg once daily for the extended treatment of venous thromboembolism (for specialized target groups only) (EN, Bayer)
26.10.17
Bayer: Sales and earnings increased (EN, Bayer)
25.10.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
24.10.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
17.10.17
Bayer submits its extended half-life hemophilia A compound for marketing authorization in Japan (for specialized target groups only) (EN, Bayer)
13.10.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
13.10.17
Bayer signs agreement to sell selected Crop Science businesses to BASF for EUR 5.9 billion (EN, Bayer)
11.10.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
09.10.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
29.09.17
Bayer cedes control of Covestro (EN, Bayer)
19.09.17
Crop Science Division of Bayer well positioned to fulfill future customer, market and societal needs (EN, Bayer)
15.09.17
Bayer receives positive CHMP opinion for rivaroxaban 10 mg once daily for the extended prevention of venous thromboembolism (for specialized target groups only) (EN, Bayer)
14.09.17
Bayer receives FDA approval for Copanlisib in adults with relapsed follicular lymphoma after two prior systemic therapies (for specialized target groups only) (EN, Bayer)
14.09.17
Bayer and Ginkgo Bioworks join forces for sustainable agriculture, forming new company with USD 100 million Series A (EN, Bayer)
12.09.17
Bayer further reduces holding in Covestro (EN, Bayer)
12.09.17
Wolfgang Nickl to be new Chief Financial Officer at Bayer AG (EN, Bayer)
07.09.17
Bayer again listed in the Dow Jones Sustainability World Index (EN, Bayer)
07.09.17
Bayer submits marketing authorization application for BAY94-9027 for the treatment of Hemophilia A in the EU (for specialized target groups only) (EN, Bayer)
22.08.17
Bayer will continue to work constructively with the European Commission (EN, Bayer)
07.08.17
Bayer Receives EU Approval for Stivarga® (regorafenib) for the Second-Line Systemic Treatment of Liver Cancer (for specialized target groups only) (EN, Bayer)
20.07.17
DGAP-Vorabbekanntmachung: Bayer (EQS Group)
30.06.17
DGAP-Ad hoc: Bayer (EQS Group)
28.06.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
23.06.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
02.06.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
15.05.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
08.05.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
31.03.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
28.03.17
DGAP-Stimmrechtsanteile: Bayer (EQS Group)
Seite: 123

Bayer News

Bayer News: auf dieser Seite finden Sie alle Bayer News und Nachrichten zur Bayer Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Bayer News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Bayer News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Zur klassischen Ansicht wechseln
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Steinhoff International N.V.A14XB9
Volkswagen (VW) AG Vz.766403
Deutsche Bank AG514000
Daimler AG710000
Deutsche Telekom AG555750
BYD Co. Ltd.A0M4W9
EVOTEC AG566480
CommerzbankCBK100
Amazon906866
Infineon AG623100
GeelyA0CACX
Apple Inc.865985
Netflix Inc.552484
Siemens AG723610
Allianz840400